Skip to content

Breatheomics of mechanically ventilated intensive care patients.

BREATHEomics Of Mechanically ventilated Intensive Care patientS.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26899
Enrollment
1500
Registered
2011-02-11
Start date
2011-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SIRS and sepsis and critical illness related organ failure

Interventions

None listed

Sponsors

Academic Medical Center, Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Intubation and mechanically ventilation and an expected ICU-stay > 24 hours.

Exclusion criteria

Exclusion criteria: 1. Age < 18 years; 2. Expected pregnancy. The following patients will be measured but are excluded from primary analyses: 3. Known chronic pulmonary condition, detectable by electronic nose (asthma, pulmonary malignancy, tuberculosis, cystic fibrosis); 4. Admitted to another ICU in the last 7 days.

Design outcomes

Primary

MeasureTime frame
1. Breathprints obtained by electronic nose (Cyranose and ContiNose); 2. Specific VOCs detected by GC-MS.

Secondary

MeasureTime frame
1. Sepsis and probability of infection; 2. Organ failure; 3. Systemic biomarkers of inflammation, coagulation, organ failure, etc; 4. Pulmonary biomarkers of inflammation, coagulation, etc; 5. Pulmonary microbiome. Other: General demographical, clinical and physiological data are collected for calculation of acute physiology, age and chronic health (APACHE) II and III scores, simplified acute physiology scores (SAPS) II, and sequential organ failure assessment (SOFA) scores. Daily laboratory include WBC & differentials, platelet counts, creatinine, ASAT, ALAT, glucose, PT, aPTT, and lactate. Infections on admission and during stay on the ICU are recorded. Outcome data include duration of mechanical ventilation, length of stay in ICU and hospital, and 30–day -, 90–day - and 1–year mortality.

Contacts

Public ContactLieuwe D.J. Bos

Academic Medical Center, Room G3-228 Meibergdreef 9

l.d.bos@amc.uva.nl+31 (0)20 5666345

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)